Skip to main content
BiomX Inc. logo

BiomX Inc. — Investor Relations & Filings

Ticker · PHGE ISIN · US09090D1037 US Manufacturing
Filings indexed 511 across all filing types
Latest filing 2026-04-30 Annual Report
Country US United States of America
Listing US PHGE

About BiomX Inc.

https://www.biomx.com/

BiomX Inc. is a clinical-stage company developing phage therapies to target and destroy harmful bacteria. The company creates both natural and engineered phage cocktails and personalized treatments for chronic diseases. Its therapeutic pipeline focuses on conditions such as cystic fibrosis and diabetic foot osteomyelitis. BiomX's platform discovers and validates proprietary bacterial targets, allowing for the customization of phage compositions against these specific pathogens.

Recent filings

Filing Released Lang Actions
10-K/A - BiomX Inc. (0001739174) (Filer)
Annual Report
2026-04-30 English
8-K - BiomX Inc. (0001739174) (Filer)
Regulatory Filings
2026-04-16 English
8-K - BiomX Inc. (0001739174) (Filer)
Regulatory Filings
2026-04-13 English
S-8 - BiomX Inc. (0001739174) (Filer)
Registration Form
2026-04-10 English
8-K - BiomX Inc. (0001739174) (Filer)
Regulatory Filings
2026-04-10 English
8-K - BiomX Inc. (0001739174) (Filer)
Regulatory Filings
2026-04-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.